Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilafruz Juraeva

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Canadian Journal of Microbiology|August 19, 2006
Detection and quantification of the nifH gene in shoot and root of cucumber plantsDilafruz Juraeva, Eckhard George, Kahramon Davranov, et al.
Scientific Reports|August 7, 2021
Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell linesKrzysztof Koras, Ewa Kizling, Dilafruz Juraeva, et al.
Scientific Reports|June 12, 2020
Feature selection strategies for drug sensitivity predictionKrzysztof Koras, Dilafruz Juraeva, Julian Kreis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the Phase II VISION study of tepotinibChristian Rolfo, Aurora O'Brate, Christoph Menzel, et al.
Genome Biology|June 10, 2022
CONET: copy number event tree model of evolutionary tumor history for single-cell dataMagda Markowska, Tomasz Cąkała, BłaŻej Miasojedow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2018
Distinct human circulating NKp30<sup>+</sup>FcεRIγ<sup>+</sup>CD8<sup>+</sup> T cell population exhibiting high natural killer-like antitumor potentialMargareta P Correia, Ana Stojanovic, Katharina Bauer, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk AssessmentCarolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Nature|May 16, 2014
Cell competition is a tumour suppressor mechanism in the thymusVera C Martins, Katrin Busch, Dilafruz Juraeva, et al.
Cancer Research|June 13, 2015
A Systematic Approach to Defining the microRNA Landscape in MetastasisGiridhar Mudduluru, Mohammed Abba, Jasmin Batliner, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Canadian Journal of Microbiology|August 19, 2006
Detection and quantification of the nifH gene in shoot and root of cucumber plantsDilafruz Juraeva, Eckhard George, Kahramon Davranov, et al.
Scientific Reports|August 7, 2021
Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell linesKrzysztof Koras, Ewa Kizling, Dilafruz Juraeva, et al.
Scientific Reports|June 12, 2020
Feature selection strategies for drug sensitivity predictionKrzysztof Koras, Dilafruz Juraeva, Julian Kreis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the Phase II VISION study of tepotinibChristian Rolfo, Aurora O'Brate, Christoph Menzel, et al.
Genome Biology|June 10, 2022
CONET: copy number event tree model of evolutionary tumor history for single-cell dataMagda Markowska, Tomasz Cąkała, BłaŻej Miasojedow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2018
Distinct human circulating NKp30<sup>+</sup>FcεRIγ<sup>+</sup>CD8<sup>+</sup> T cell population exhibiting high natural killer-like antitumor potentialMargareta P Correia, Ana Stojanovic, Katharina Bauer, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk AssessmentCarolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Nature|May 16, 2014
Cell competition is a tumour suppressor mechanism in the thymusVera C Martins, Katrin Busch, Dilafruz Juraeva, et al.
Cancer Research|June 13, 2015
A Systematic Approach to Defining the microRNA Landscape in MetastasisGiridhar Mudduluru, Mohammed Abba, Jasmin Batliner, et al.
Oncotarget|April 11, 2015
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastomaDiana T Lau, Claudia L Flemming, Samuele Gherardi, et al.
Pageof 3